Asieris Pharmaceuticals

A global pharma company specializing in new drugs for the treatment of genitourinary tumors and other major diseases.

Launch date

2010

Employees

Market cap

Enterprise valuation

Shanghai Shanghai (HQ)

Date	Investors	Amount	Round
-	Phoenix Investment TF Capital Yanchuang Capital Zhongguancun Development Group	N/A	-
Dec 2016	N/A	N/A	Series A
Dec 2017	N/A	N/A	Series B
Mar 2020*	Kaitai Capital Shenzhen Guozhong Venture Capital Management Lapam Capital Efund Capital	$14.0m	Series C
Nov 2020*	CICC YunFeng Capital Qiming Venture Partners Gopher Asset Management SAIC Investment V-Capital TriWise Capital IFSC In Capital Xiamen C&D Shanghai Hongxin Equity Investment Fund Management Haoshuo Zhier Fund	CNY700m	Series D
Total Funding		CAD150m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Asieris Pharmaceuticals